Showing posts with label Quality. Show all posts
Showing posts with label Quality. Show all posts

Friday, December 7, 2012

Balancing Quality And Quantity Of Life For Pancreatic Cancer Patients

Main Category: Pancreatic Cancer
Article Date: 27 Aug 2012 - 0:00 PDT Current ratings for:
Balancing Quality And Quantity Of Life For Pancreatic Cancer Patients
not yet ratednot yet rated
Every year, nearly 45,000 Americans are diagnosed with pancreatic cancer. The odds against those stricken by the disease are truly dismal; pancreatic cancer almost always kills within two years after diagnosis, no matter how it is treated. Even aggressive intervention with chemotherapy, radiation or surgery rarely yields more than an extra month to a year of survival, depending on the stage of the disease.

This raises a tough question: should patients who know they are going to die soon spend a substantial amount of what little time they have left undergoing aggressive and difficult treatment - treatment likely to bring them only a brief period of additional life?

"It's about balancing quality and quantity of life, really," said Dr. Casey Boyd, a University of Texas Medical Branch at Galveston surgery resident and lead author of a paper analyzing the problem in Annals of Surgical Oncology. "For pancreatic cancer we know the quantity of life is short, so maximizing the quality of life is important - and the best way we can do that is to give patients concrete data that they can look at and use in their treatment decisions."

Boyd and her colleagues approached the issue by drawing on the National Cancer Institute's Surveillance, Epidemiology and End Results database, examining SEER records for 25,476 pancreatic cancer patients and focusing on two factors that directly affect patients' lives: hospital days and days spent in medical care. (Hospital days were days spent as hospital inpatients, while medical care days included days in the hospital as well as other days on which the patient visited a physician, underwent a diagnostic test, or received a treatment).

"This study is the first to bring together hospital and medical care days in pancreatic cancer patients with stage, treatment and survival, and it gives us a quantitative look at the whole experience of a patient with pancreatic cancer," Boyd said. "We hope that physicians can use the information in this paper to give patients what they need to make critical decisions."

For example, Boyd said, a doctor could draw on the paper to counsel a patient with metastatic pancreatic cancer - the most common and deadly type. "The physician could say, if you have chemotherapy you may live four to six weeks longer, but a lot of that time you're going to be in the hospital, or getting a test, or getting a needle poked in your arm for your chemotherapy," she said. "Some patients may say, I want that, I want the most life that you can give me."

Others, she noted, might make a different choice if given an accurate picture of the treatment experience.

"They might say, it's not really worth it to me - it's a few extra weeks, but they may be miserable weeks," Boyd said. "They may decide not to have any treatment and maybe just have hospice, or just spend time with their family."

The ability to help patients make such difficult decisions was the main goal of the study, according to Boyd.

"Really, this paper is about empowering the patient," she said. "We want to provide them with the information they need to make their own personalized treatment decisions."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our pancreatic cancer section for the latest news on this subject. Other authors of the Annals of Surgical Oncology article include medical student Daniel Branch, assistant professor Kristin Sheffield, biostatistician Yimei Han, associate professor Yong-Fang Kuo, Sealy Center on Aging director Dr. James Goodwin and associate professor Dr. Taylor Riall. Support for this research was provided by the NCI; the Office of Research, Development and Information, Centers for Medicare & Medicaid Services; Information Management Services Inc.; the SEER program; and the Cancer Prevention Research Institute of Texas.
University of Texas Medical Branch at Galveston Please use one of the following formats to cite this article in your essay, paper or report:

MLA

n.p. "Balancing Quality And Quantity Of Life For Pancreatic Cancer Patients." Medical News Today. MediLexicon, Intl., 27 Aug. 2012. Web.
12 Nov. 2012. APA

Please note: If no author information is provided, the source is cited instead.


'Balancing Quality And Quantity Of Life For Pancreatic Cancer Patients'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Friday, November 16, 2012

Quality of life once the cancer may depend on the type of Tumor

health day

Certain types leave survivors with worse mental and physical well-being, study findsTuesday, October 30 HealthDay News)-the quality of life of cancer survivors may vary depending on the type of cancer, and millions of United States cancer survivors have a lower quality than normal life, a new study finds.

The researchers looked at more than 1,800 survivors of cancer in adults and more than 24,000 adults without a history of cancer and found that the survivors of cancers of prostate, breast and melanoma a mental - and Fisica-salud - quality of life similar to those who never had cancer.

Survivors of cervical, blood and colorectal cancer as well as cancer survivors with a survival rate of five years of less than 25 per cent (such as liver, lung and pancreatic cancer), however, had worse Fisica-salud - quality of life.

And the survivors of cervical cancer and cancer with a five-year survival rate low also had poorer mental-health-quality of life, according to the study, which was published in the October 30 in the journal Epidemiology, biomarkers & prevention of cancer.

The researchers found that 25 percent of cancer survivors had lower normal Fisica-salud - quality of life, and 10 percent lower than normal mental health quality of life-related. In total, about 3.3 million United States cancer survivors have a physical life quality of below average and nearly 1.4 million have one below the average mental quality of life, the researchers estimated.

"It is very concerning there are a significant number of cancer survivors that years of poor physical or mental health after cancer experience", study author Kathryn Weaver, an Assistant Professor at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, said in a press release from the journal.

"Our results serve as a basis so that in five to 10 years, we can evaluate whether current approaches to improve the health and well-being of cancer survivors are having a positive effect," he said. "I also hope our data will be calling attention to the needs of survivors of cancer, especially those with cervical, blood and less common cancers - and the importance of the supervision of these individuals, even long after his diagnosis of cancer."

More information

The national United States cancer Institute has more about life after cancer treatment.

Source: Cancer Epidemiology, biomarkers & prevention, press release, 30 October 2012

Copyright © 2010 HealthDay. All rights reserved.


View the original article here